Xencor Inc (XNCR)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Dr. Ellen Gwen FeigalIndependent Director | -6.84k | 89.37k | Automatic Disposition | 13.06 | 12.34k | -35.67% |
| 2026-06-15 | Dr. Kevin C. GormanIndependent Director | -7.53k | 92.66k | Automatic Disposition | 12.31 | 11.38k | -39.81% |
| 2026-06-15 | Mr. Richard J. RanieriIndependent Director | -5.47k | 67.38k | Automatic Disposition | 12.31 | 13.71k | -28.54% |
| 2026-06-15 | Mr. Kurt A. GustafsonIndependent Director | -5.47k | 67.38k | Automatic Disposition | 12.31 | 14.71k | -27.12% |
| 2026-06-15 | Dr. Alan Bruce Montgomerylead Independent Director | -5.06k | 62.34k | Automatic Disposition | 12.31 | 15.55k | -24.57% |
| 2026-04-10 | Mr. Bart Jan CornelissenSenior VP & CFO | -3.50k | 42.99k | 売り | 12.29 | 27.72k | -11.21% |
| 2026-03-05 | Ms. Celia E. EckertSenior VP, General Counsel & Corporate Secretary | -5.01k | 55.95k | 売り | 11.02 - 11.25 | 39.24k | -11.32% |
| 2026-03-05 | Dr. John R. DesjarlaisExec. VP of Research & Chief Scientific Officer | -6.62k | 73.88k | 売り | 11.02 - 11.25 | 212.12k | -3.03% |
| 2026-03-05 | Dr. Bassil I. DahiyatCo-Founder, CEO, President & Director | -21.48k | 240.02k | 売り | 11.02 - 11.25 | 357.68k | -5.66% |
| 2026-03-05 | Mr. Bart Jan CornelissenSenior VP & CFO | -2.52k | 28.30k | 売り | 11.25 | 17.13k | -12.81% |
| 2026-03-03 | Dr. John R. DesjarlaisExec. VP of Research & Chief Scientific Officer | -2.66k | 31.68k | 売り | 11.90 | 201.88k | -1.30% |
| 2026-03-03 | Dr. Bassil I. DahiyatCo-Founder, CEO, President & Director | -6.76k | 80.39k | 売り | 11.90 | 324.40k | -2.04% |
| 2026-03-03 | Ms. Celia E. EckertSenior VP, General Counsel & Corporate Secretary | -1.49k | 17.75k | 売り | 11.90 | 32.57k | -4.38% |
| 2026-01-23 | Dr. John R. DesjarlaisExec. VP of Research & Chief Scientific Officer | 5.32k | 66.58k | Derivative Exercise and Retained Stock | 12.51 | 198.29k | 2.76% |
| 2025-12-22 | Dr. Bassil I. DahiyatCo-Founder, CEO, President & Director | 10.62k | 132.91k | Derivative Exercise and Retained Stock | 12.51 | 313.65k | 3.51% |
| 2025-12-19 | Dr. Bassil I. DahiyatCo-Founder, CEO, President & Director | -114.38k | 366.01k | Derivative Exercise and Sale | 12.51 - 15.71 | 313.65k | - |
| 2025-12-22 | Dr. John R. DesjarlaisExec. VP of Research & Chief Scientific Officer | 6.31k | 78.95k | Derivative Exercise and Retained Stock | 12.51 | 192.97k | 3.38% |
| 2025-12-19 | Dr. John R. DesjarlaisExec. VP of Research & Chief Scientific Officer | -73.37k | 235.51k | Derivative Exercise and Sale | 12.51 - 15.72 | 192.97k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。